Evidence map›Paper›PMID 37251325›Full record

ArticleFrontiers in pharmacology2023

Amino acid modified OCMC-g-Suc-

Li Cui, Xiaolan Liu, Rongjun Yan, Qixu Chen, Lizhen Wang, Shah Nawaz, Dawei Qin, Daijie Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Li CuiSchool of Chemistry and Chemical Engineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China.
Xiaolan LiuJinan Authority Hospital, Jinan, China.
Rongjun YanJinan International Travel Healthcare Center, Jinan, China.
Qixu ChenBiological Engineering Technology Innovation Center of Shandong Province, Heze Branch of Qilu University of Technology (Shandong Academy of Sciences), Heze, China.
Lizhen WangBiology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China.
Shah NawazDepartment of Chemistry, Karakoram International University, Gilgit, Pakistan.
Dawei QinSchool of Chemistry and Chemical Engineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China.
Daijie WangShandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China.
Shandong Academy of Sciences · CNQilu University of Technology · CNJinan Maternity And Care Hospital · CNKarakoram International University · PKShenzhen International Travel Health Care Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanohydrogels show great potential as efficient drug carriers due to their biocompatibility, low toxicity, and high water absorbability. In this paper, we prepared two

Indexed as

anticancer activityginsenoside Rg1lapatinibOCMC-g-β-CD nanohydrogelszebrafish

Identifiers

PMID37251325
PMCPMC10210146
OpenAlexW4378745373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.